Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Apr 16.
Published in final edited form as: Angew Chem Int Ed Engl. 2019 Mar 20;58(17):5653–5657. doi: 10.1002/anie.201900503

Cycloadditions of Oxacyclic Allenes and a Catalytic Asymmetric Entryway to Enantioenriched Cyclic Allenes

Michael M Yamano 1, Rachel R Knapp 2, Aurapat Ngamnithiporn 3, Melissa Ramirez 4, Kendall N Houk 5, Brian M Stoltz 6, Neil K Garg 7
PMCID: PMC6456397  NIHMSID: NIHMS1019240  PMID: 30811080

Abstract

The chemistry of strained cyclic alkynes has undergone a renaissance over the past two decades. However, a related species, strained cyclic allenes, especially heterocyclic derivatives, have only recently resurfaced and represent another class of valuable intermediates. We report a mild and facile means to generate the parent 3,4-oxacyclic allene from a readily accessible silyl triflate precursor, and trap it in (4+2), (3+2), and (2+2) reactions to provide a variety of cycloadducts. In addition, we describe a catalytic, decarboxylative asymmetric allylic alkylation performed on an α-silylated substrate, to ultimately permit access to an enantioenriched allene. Generation and trapping of the enantioenriched cyclic allene occurs with complete transfer of stereochemical information in a Diels–Alder cycloaddition via a point chirality, axial chirality, point chirality transfer process.

Keywords: cyclic allenes, cycloadditions, enantioselective, heterocycles, catalysis

Graphical Abstract

graphic file with name nihms-1019240-f0001.jpg

We report a mild and facile means to generate 3,4-oxacyclohexadiene and trap it in situ in (4+2), (3+2), and (2+2) reactions. In addition, we describe a catalytic, asymmetric approach for arriving at enantioenriched cyclic allene precursors.


Despite once being mere scientific curiosities, strained cyclic intermediates have become a popular arena for chemical discoveries. A notable breakthrough in the field was the discovery of benzyne (1), initially proposed by Wittig in 1942 and validated by Roberts in 1953 (Figure 1).1 In the modern era, benzyne (1) and other cyclic alkynes are readily used to make natural products,2 medicinal agents,3 agrochemicals,4 materials,5 tools for chemical biology,6 and ligands for catalysis.7, 8 The related intermediate 1,2-cyclohexadiene (2) has generally received less attention despite being validated not long after benzyne (1) in 1966.9 Historically, theoretical studies of 2 and its derivatives have been popular.10 However, only recently has 2 seen synthetic use in cycloadditions.11 This is largely due to its ability to be accessed under mild fluoride-mediated conditions from silyl triflate 3.12,13

Figure 1.

Figure 1.

Highlights of benzyne and cyclic allene chemistry and cycloadditions of oxacyclic allenes described in this study. OTf=trifluoromethanesulfonate.

One exciting opportunity in the field of strained cyclic intermediates is the ability to access heterocyclic allenes. Early efforts in this field relied on harsh reaction conditions;14, 15 however, we recently demonstrated that azacyclic allenes 4 (Figure 1) can be accessed using mild reaction conditions. Moreover, using chiral separation technology, enantioenriched 4 was intercepted (R=Cbz, R’=H, R’’=Me), and its stereospecific trapping allowed for a unique approach to access enantioenriched cycloadducts.16

Given the potential for heterocyclic allenes to provide a facile means to rapidly assemble stereochemically-rich scaffolds,16 we questioned if oxacyclic allenes 6 could be employed efficiently in cycloadditions to access oxygen-containing heterocycles.17 Oxygenated heterocycles are often seen in natural products and drugs18, 19, 20, 21 and are known bioisosteres for their nitrogen and sulfur-containing counterparts.22 A single report by Christl demonstrated that 6 (R’=H) could be generated using the Doering–Moore–Skattebøl rearrangement, however, this required harsh organolithium-based conditions.14 If 6 could be generated under mild conditions from silyl triflates 5, the untapped synthetic utility of this species could be unlocked. Additionally, we sought to establish a catalytic, asymmetric method to access 6 in enantioenriched form, ideally by preparing an enantioenriched precursor to the desired allene 6. By accessing enantioenriched 5, we could explore the possibility of transferring stereochemical information from allene precursor 5 to cycloadduct 7, via a point chirality, axial chirality, point chirality transfer process. The results presented herein not only demonstrate the scope and utility of oxacyclic allene cycloadditions, but also showcase an exciting strategy that merges asymmetric catalysis with cyclic allene chemistry as a means to access enantioenriched scaffolds.

Density functional theory (DFT) calculations on the structure of heterocyclic allene 8 were performed using ωB97XD/6–31G(d) (Figure 3).10a, 10c, 10d, 23 The C=C bond length of the allene is 1.32 Å, which is only slightly longer than the C=C bond length in a linear allene.16 Furthermore, the internal angle at the central allene carbon is 133°, which is a significant deviation from the typical internal angle of 180° seen in linear allenes. The allene π orbitals in 8 are not perfectly orthogonal, resulting in the C–H bonds being twisted out-of-plane (i.e., 38° and 41°). Thus, 8 is inherently chiral, analogous to linear allenes. The ground state geometry deviates from C2 symmetry because the molecule adopts an envelope shape; inversion of the envelope requires only 0.8 kcal/mol. Interestingly, oxacyclic allene 8 is calculated to possess 31.0 kcal/mol of strain energy, which is nearly 4 kcal/mol more than the azacyclic variant we previously reported.16 This difference can be attributed to the smaller atomic radius of oxygen and the shorter C–O bond length relative to the C–N bond length in the azacyclic variant. The significant strain associated with oxacyclic allene 8 was expected to promote rapid cycloadditions.

Figure 3.

Figure 3.

(3+2) cycloadditions with nitrones. The major diastereomeric product is shown. Yields reflect an average of two isolation experiments. Diastereomeric ratios were determined by 1H NMR analysis of the crude reaction mixture. OTf=trifluoromethanesulfonate, Ts = para-toluenesulfonyl.

With the aim of accessing oxacyclic allene 8, we first targeted silyl triflate 12 (Scheme 1), given the wide synthetic utility of silyl triflates as precursors to strained alkyne and allene intermediates.12, 24 Bromoketone 9 (commercially available or readily synthesized from tetrahydro-4-pyranone) was converted to triethylsilyl enol ether 10 upon treatment with DABCO and TESCl.25 Subsequent retro-Brook rearrangement furnished the desired α-silyl ketone 11. Lastly, triflation afforded silyl triflate 12.16 Our three step, scalable26 synthesis of 12 provides a new strategy to synthesize α-silyl ketones en route to cyclic allene precursors. Currently, α-silyl ketones are most commonly prepared by 1,4-reduction of the corresponding α,β-unsaturated ketones.11a, 12, 16, 27

Scheme 1.

Scheme 1.

Synthesis of silyl triflate 12. DABCO=1,4-diazabicyclo[2.2.2]octane, DMF=N,N-dimethylformamide, THF=tetrahydrofuran, LDA=lithium diisopropylamide, Comins’ Reagent=N-(5-Chloro-2-pyridyl)bis(trifluoromethanesulfonimide).

With silyl triflate 12 in hand, we generated and trapped 8 in Diels–Alder, (3+2), and (2+2) cycloadditions. By simply employing a variety of dienes, a number of cycloadducts were prepared in good to excellent yields (Table 1, entries 1–5).28 In almost all cases, the reactions were performed at 23 °C, thus highlighting the mildness of the reaction conditions. Although the range of disastereoselectivities is variable, in all examples, the major diastereomer observed is the endo product. Furthermore, the observed selectivities are supported by computations as the endo transition states were found to be more energetically favorable compared to the exo transition states.26 It should be noted that in each case, the products formed are considerably complex from a structural perspective, each bearing three stereocenters, a bridged [2.2.1]-bicyclic framework, and 1 or 2 heteroatoms.

Table 1.

Mild generation of oxacyclic allene 8 and its trapping in Diels–Alder cycloadditions.

graphic file with name nihms-1019240-t0007.jpg
[a]

The major diastereomer is shown.

[b]

Yields reflect an average of two isolation experiments.

[c]

Diastereomeric ratios were determined by 1H NMR analysis of the crude reaction mixture.

[d]

The reaction was performed at 60 °C for 2.5 h using 2.0 equiv of diene 21. OTf=trifluoromethanesulfonate, Boc=tert-butyloxycarbonyl.

The results of the (3+2) and (2+2) cycloadditions are shown in Figure 3 and Table 2. The use of simple nitrones gave high yields of isoxazolidine products 2729, whereas nitrones bearing either an indole or quinoline unit delivered cycloadducts 30 and 31. We also evaluated two cyclic nitrones where R’’ and R’’’ of 25 were tethered, which furnished tri- and tetracyclic products 32 and 33. Additionally, a ketone-derived nitrone was utilized, ultimately giving rise to the heteroatom-rich trifluoromethylated product 34. Azomethine imines 37 and 39 were tested, giving rise to the corresponding pyrazolidines, 38 and 40, in good to excellent diastereoselectivities (Table 2, entries 1 and 2). The use of nitrile oxide 41 led to the formation of isoxazoline 42 in 91% yield (entry 3). With regard to a (2+2) cycloaddition, the use of indene gave cyclobutane 44 in excellent yield and with high regioselectivity (entry 4).

Table 2.

Additional (3+2) and (2+2) cycloadditions.

graphic file with name nihms-1019240-t0008.jpg
[a]

The major diastereomer is shown.

[b]

Yields reflect an average of two isolation experiments.

[c]

Diastereomeric ratios were determined by 1H NMR analysis of the crude reaction mixture. OTf=trifluoromethanesulfonate.

Overall, silyl triflate 12 was elaborated to 17 different sp3-rich heterocyclic cycloadducts. Several of these bear a multitude of rings, stereocenters, and heteroatoms, thus showcasing the value of oxacyclic allenes for the rapid generation of complex scaffolds. Accordingly, this methodology should be especially valuable to those pursuing modern drug discovery efforts.17

As noted earlier, one of the most exciting opportunities regarding cyclic allene chemistry is the possibility of intercepting enantioenriched allenes for the synthesis of enantioenriched cycloadducts. In a seminal study, Christl and Engels generated 1-phenyl-1,2-cyclohexadiene in enantioenriched form, as judged by the formation of an enantioenriched cycloadduct, albeit in low yield, likely owing to the necessary use of organolithium reagents.29 Our laboratory recently disclosed a mild, alternative strategy whereby silyl triflate precursors to the desired cyclic allenes could be employed in enantioenriched form.16 However, in both cases, the key substrates were only accessible via chiral separation technologies. A catalytic asymmetric strategy to access enantioenriched cyclic allene precursors has not been disclosed.

Our efforts in this area are highlighted in Scheme 2. Enol carbonate 45 was formed by intercepting the enolate intermediate generated during the retro-Brook rearrangement of 10 (see Scheme 1). This set the stage for a Pd-catalyzed decarboxylative asymmetric allylic alkylation. Allylation was attractive, given that allyl groups serve as versatile handles for further manipulation.30 After extensive experimentation,26 it was found that treatment of 45 with Pd(dmdba)2 and (S)-(CF3)3-tBu-PHOX ligand 47 in toluene at –10 °C gave the desired ketone 46 in 9:1 er (81% ee) and 75% yield. This is the first example of a decarboxylative asymmetric allylic alkylation reaction being performed on an α-silyl-substituted enol carbonate. In fact, decarboxylative asymmetric allylic alkylations on substrates bearing α-heteroatoms are significantly underdeveloped.30, 31 46 was converted to silyl triflate 48 in one-step, thus establishing the first catalytic asymmetric strategy for the synthesis of enantioenriched cyclic allene precursors.

Scheme 2.

Scheme 2.

Catalytic asymmetric approach and cycloaddition results. dmdba=3,5,3′,5′-dimethoxydibenzylideneacetone, KHMDS= potassium bis(trimethylsilyl)amide, Comins’ Reagent=N-(5-Chloro-2-pyridyl)bis(trifluoromethanesulfonimide), THF=tetrahydrofuran.

48 was treated with trapping agent 50 or 19 in the presence of CsF in acetonitrile at 23 °C. Interestingly, the nitrone cycloadduct, isoxazolidine 51, was obtained in 21% ee. On the other hand, the Diels–Alder cycloadduct, oxabicycle 52, was obtained in 81% ee (>20:1 dr), reflective of complete transfer of stereochemical information. Given this latter result, we surmise that enantioenriched 49 is formed under the mild reaction conditions with complete transfer of stereochemical information. In the case of the nitrone trapping, previous computational studies have demonstrated that trapping may occur through either a stepwise or concerted pathway,11a which acounts for the partial loss of stereochemical information.32 However, in the case of the Diels–Alder reaction, it is likely that a concerted pathway is operative, based on our recent computational investigation of azacyclic allenes,16 thus leading to complete transfer of stereochemical information.

The overall conversion of 48 to 49 to 52 deserves special attention. This is a scenario wherein the silyl-bearing stereocenter in 48 was ultimately accessed by asymmetric catalysis. The point chirality in 48 is then transferred to the axially chiral transient intermediate 49, which is then relayed to product 52, which possesses point chirality. Enantioenriched cycloadduct 52 contains three stereocenters, none of which were present in the starting material that bears only one stereocenter. The transformation occurs preferrentially with the olefin more distal to the 2-phenyl allyl group undergoing cycloaddition. This is presumably because of favorable electronic interactions in the transition state based on our prior studies,16 however, we cannot rule out the steric impact of the 2-Ph allyl chain as a contributor to the observed regioselectivity.

We have discovered an efficient synthetic route to prepare a silyl triflate precursor to 3,4-oxacyclohexadiene, the first generation of an oxacyclic allene under mild conditions, and the in situ trapping of the oxacyclic allene in diastereo- and regioselective cycloadditions. These efforts collectively establish the synthetic utility of oxacyclic allenes for the rapid generation of complex heterocyclic scaffolds. In addition, we have uncovered the first catalytic, asymmetric approach to access an enantioenriched cyclic allene precursor. This relies on a Pd-catalyzed allylic allylation, performed for the first time on an α-silyl substituted substrate, ultimately permitting access to the necessary enantioenriched silyl triflate precursor. We show that trapping of the enantioenriched oxacyclic allene in a Diels–Alder reaction occurs with complete transfer of stereochemical information via a point chirality, axial chirality, point chirality transfer process. These results showcase an exciting strategy that merges asymmetric catalysis with cyclic allene chemistry as a means to access densely functionalized, enantioenriched scaffolds.

Supplementary Material

Supp info

Figure 2.

Figure 2.

Ground state structure of oxacyclic allene 8. The structure was computed using ωB97XD/6–31G(d).

Acknowledgements

The authors are grateful to NIH-NIGMS (R01 GM123299-01A1 and R01 GM117016 to N. K. G. and R01GM080269 to B.M.S), Caltech, and UCLA for support. M. M. Y. acknowledges the National Science Foundation GRFP (DGE-1144087). A. N. thanks the Royal Thai Government Scholarship Program. Dr. Scott Virgil (Caltech) is thanked for instrumentation and SFC assistance. These studies were supported by shared instrumentation grants from the NSF (CHE-1048804) and the National Center for Research Resources (S10RR025631). This study used computational and storage services associated with the Hoffman2 Shared Cluster provided by UCLA Institute for Digital Research and Education’s Research Technology Group.

Contributor Information

Michael M. Yamano, Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095 (USA)

Rachel R. Knapp, Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095 (USA)

Aurapat Ngamnithiporn, The Warren and Katharine Schlinger Laboratory of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125 (USA).

Melissa Ramirez, Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095 (USA).

Prof. Dr. Kendall N. Houk, Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095 (USA)

Prof. Dr. Brian M. Stoltz, The Warren and Katharine Schlinger Laboratory of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125 (USA)

Prof. Dr. Neil K. Garg, Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095 (USA)

References

  • 1.a) Wittig G, Naturwissenschaften 1942, 30, 696–703; [Google Scholar]; b) Roberts JD, Simmons HE, Carlsmith LA, Vaughn CW, J. Am. Chem. Soc 1953, 75, 3290–3291. [Google Scholar]
  • 2.a) For recent examples of arynes and related species in total synthesis, see: Kou KGM, Pflueger JJ, Kiho T, Morrill LC, Fisher EL, Clagg K, Lebold TP, Kisunzu JK, Sarpong R, J. Am. Chem. Soc 2018, 140, 8105–8109; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Goetz AE, Silberstein AL, Corsello MA, Garg NK, J. Am. Chem. Soc 2014, 136, 3036–3039; [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Neog K, Borah A, Gogoi P, J. Org. Chem 2016, 81, 11971–11977; [DOI] [PubMed] [Google Scholar]; d) Neumeyer M, Kopp J, Brückner R, Eur. J. Org. Chem 2017, 2883–2915; [Google Scholar]; e) Corsello MA, Kim J, Garg NK, Nat. Chem 2017, 9, 944–949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.a) Carroll FI, Robinson TP, Brieaddy LE, Atkinson RN, Mascarella SW, Damaj MI, Martin BR, Navarrio HA, J. Med. Chem 2007, 50, 6383–6391; [DOI] [PubMed] [Google Scholar]; c) Willis PG, Pavlova OA, Chefer SI, Vaupel DB, Mukhin AG, Horti AG, J. Med. Chem 2005, 48, 5813–5822; [DOI] [PubMed] [Google Scholar]; d) Jacob P III, J. Med. Chem 1981, 24, 1348–1353; [DOI] [PubMed] [Google Scholar]; e) Coe JW, et al. , Bioorg. Med. Chem. Lett 2005, 15, 4889–4897. [DOI] [PubMed] [Google Scholar]
  • 4.Schleth F, Vettiger T, Rommel M, Tobler H, WO2011131544 A1, 2011. [Google Scholar]
  • 5.Lin JB, Shah TJ, Goetz AE, Garg NK, Houk KN, J. Am. Chem. Soc 2017, 139, 10447–10455. [DOI] [PubMed] [Google Scholar]
  • 6.Chupakhin EG, Krasavin MY, Chem. Heterocycl. Compd 2018, 54, 483–501. [Google Scholar]
  • 7.a) Surry DS, Buchwald SL, Angew. Chem. Int. Ed 2008, 47, 6338–6361; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem 2008, 120, 6438–6461; [Google Scholar]; b) Mauger CC, Mignani GA, Org. Proc. Res. Dev 2004, 8, 1065–1071. [Google Scholar]
  • 8.a) For recent reviews of arynes and related intermediates, see: Goetz AE, Garg NK, J. Org. Chem 2014, 79, 846–851; [DOI] [PubMed] [Google Scholar]; b) Yoshida S, Hosoya T, Chem. Lett 2015, 44, 1450–1460; [Google Scholar]; c) Bhojgude SS, Bhunia A, Biju AT, Acc. Chem. Res 2016, 49, 1658–1670; [DOI] [PubMed] [Google Scholar]; d) Shi J, Li Y, Li Y, Chem. Soc. Rev 2017, 46, 1707–1719; [DOI] [PubMed] [Google Scholar]; e) Asamdi M, Chikhalia KH, Asian J. Org. Chem 2017, 6, 1331–1348; [Google Scholar]; f) Idiris FIM, Jones CR, Org. Biomol. Chem 2017, 15, 9044–9056; [DOI] [PubMed] [Google Scholar]; g) Takikawa H, Nishii A, Sakai T, Suzuki K, Chem. Soc. Rev 2018, 47, 8030–8056; [DOI] [PubMed] [Google Scholar]; h) Dhokale RA, Mhaske SB, Synthesis 2018, 50, 1–16. [Google Scholar]
  • 9.Wittig G, Fritze P, Angew. Chem. Int. Ed 1966, 5, 846; [Google Scholar]; Angew. Chem 1966, 78, 905. [Google Scholar]
  • 10.a) Angus RO, Schmidt MW, Johnson RP, J. Am. Chem. Soc 1985, 107, 532–537; [Google Scholar]; b) Engels B, Schöneboom JC, Münster AF, Geoetsch S, Christl M, J. Am. Chem. Soc 2002, 124, 287–297; [DOI] [PubMed] [Google Scholar]; c) Schmidt MW, Angus RO, Johnson RP, J. Am. Chem. Soc 1982, 104, 6838–6839; [Google Scholar]; d) Dillion PW, Underwood GR, J. Am. Chem Soc 1974, 96, 779–787; [Google Scholar]; e) Daoust KJ, Hernandez SM, Konrad KM, Mackie I, Winstanley J, Johnson RP, J. Org. Chem 2006, 71, 5708–5714. [DOI] [PubMed] [Google Scholar]
  • 11.a) Barber JS, Styduhar ED, Pham HW, McMahon TC, Houk KN, Garg NK, J. Am. Chem. Soc 2016, 138, 2512–2515; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Lofstrand VA, West FG, Chem. Eur. J 2016, 22, 10763–10767. [DOI] [PubMed] [Google Scholar]
  • 12.Quintana I, Peña D, Pérez D, Guitián E, Eur. J. Org. Chem 2009, 5519–5524. [Google Scholar]
  • 13.Additionally, 1,2-cyclohexadiene has been generated through a similar silyl bromide elimination: Shakespeare WC, Johnson RP, J. Am. Chem. Soc 1990, 112, 8578–8579. [Google Scholar]
  • 14.Schreck M, Christl M, Angew. Chem. Int. Ed 1987, 26, 690–692; [Google Scholar]; Angew. Chem 1987, 99, 720–721. [Google Scholar]
  • 15.a) For heterocyclic allene generation under harsh conditions or utilizing highly basic reagents, see; Christl M, Braun M, Wolz E, Wagner W, Chem. Ber 1994, 127, 1137–1142; [Google Scholar]; b) Ruzziconi R, Naruse Y, Schlosser M, Tetrahedron 1991, 47, 4603–4610; [Google Scholar]; c) Drinkuth S, Groetsch S, Peters E, Peters K, Christl M, Eur. J. Org. Chem 2001, 2665–2670. [Google Scholar]
  • 16.Barber JS, Yamano MM, Ramirez M, Darzi ER, Knapp RR, Liu F, Houk KN, Garg NK, Nat. Chem 2018, 10, 953–960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Blakemore DC, Castro L, Churcher I, Rees DC, Thomas AW, Wilson DM, Wood A, Nat. Chem 2018, 10, 383–394. [DOI] [PubMed] [Google Scholar]
  • 18.a) Atul G, Amit K, Ashutosh R, Chem. Rev 2013, 113, 1614–1640;23214501 [Google Scholar]; b) Radadiya A, Shah A, Eur. J. Med. Chem 2015, 97, 356–376. [DOI] [PubMed] [Google Scholar]
  • 19.a) Klayman DL, Science 1985, 228, 1049–1055; [DOI] [PubMed] [Google Scholar]; b) Dondorp AM, et al. , N. Engl. J. Med 2009, 361, 455–467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Montgomery CT, Cassels BK, Shamma M, J. Nat. Prod 1983, 46, 441–453. [Google Scholar]
  • 21.Salaski EJ, et al. , J. Med. Chem 2009, 52, 2181–2184. [DOI] [PubMed] [Google Scholar]
  • 22.a) Tomaszewski Z, et al. , J. Med. Chem 2005, 48, 926–934;15715463 [Google Scholar]; c) Nevagi RJ, Dighe SN, Eur. J. Med. Chem 2015, 97, 561–581; [DOI] [PubMed] [Google Scholar]; d) Zhang S, Zhen J, Reith MEA, Dutta AK, Bioorg. Med. Chem 2004, 12, 6301–6315; [DOI] [PubMed] [Google Scholar]; e) Zhang S, Reith MEA, Dutta AK, Bioorg. Med. Chem. Lett 2003, 13, 1591–1595. [DOI] [PubMed] [Google Scholar]
  • 23. The racemization barrier for 3,4-oxacyclohexadiene (8) was calculated to be 15.2 kcal/mol (ωB97XD/6–311+G(d,p)/SMD(MeCN)). In comparison, the racemization barrier for 3,4-azacyclohexadiene was found to be 14.7 kcal/mol.
  • 24.Himeshima Y, Sonoda T, Kobayashi H, Chem. Lett 1983, 12, 1211–1214. [Google Scholar]
  • 25.Shah TK, Medina JM, Garg NK, J. Am. Chem. Soc 2016, 138, 4948–4954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. See the SI for details.
  • 27.Recently, an innovative approach to a 1,2-cyclohexadiene precursor was reported; see: Inoue K, Nakura R, Okano K, Mori A, Eur. J. Org. Chem 2018, 3343–3347. [Google Scholar]
  • 28. In the absence of a trapping partner, (2+2) dimerization of the allene is observed.
  • 29.Christl M, Fischer H, Arnone M, Engels B, Chem. Eur. J 2009, 15, 11266–11272. [DOI] [PubMed] [Google Scholar]
  • 30.Behenna DC, et al. , Chem. Eur. J 2011, 17, 14199–14223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.a) For recent examples, see: Vita MV, Caramenti P, Waser J, Org. Lett 2015, 17, 5832–5835; [DOI] [PubMed] [Google Scholar]; b) Hong AY, Bennett NB, Krout MR, Jensen T, Harned AM, Stoltz BM, Tetrahedron 2011, 67, 10234–10248; [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Kondo H, Maeno M, Hirano K, Shibata N, Chem. Commun 2018, 54, 5522–5525; [DOI] [PubMed] [Google Scholar]; d) Skardon-Duncan J, Sparenberg M, Bayle A, Alexander S, Stephen CJ, Org. Lett 2018, 20, 2782–2786; [DOI] [PubMed] [Google Scholar]; e) Zhang Z-W, Wang C-C, Xue H, Dong Y, Yang J-H, Shouxin L, Wen-Qing L, Wei-Dong Z, Org. Lett 2018, 20, 1050–1053; [DOI] [PubMed] [Google Scholar]; f) Lian W-F, Wang C-C, Kang H-P, Li H-L, Feng J, Liu S, Zhang Z-W, Tetrahedron Lett 2017, 58, 1399–1402. [Google Scholar]
  • 32. Another plausible explanation for 55 being obtained in diminished ee is that racemization of 53 occurs more readily than the nitrone cycloaddition. However, the kinetic barriers for nitrone and Diels–Alder cycloadditions on related systems have been calculated to be roughly 14 kcal / mol and 19 kcal / mol, respectively (see references 11a and 16). Since the Diels–Alder cycloaddition appears to be a more challenging process, yet proceeds with complete enantiospecificity, we disfavor racemization of 53 as being the cause of partial loss of ee in the case of 55.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp info

RESOURCES